Cellular sources and immune functions of interleukin-9

Nature Reviews Immunology

Volumn 10, Issue 10, 2010, Pages 683-687

  Noelle, Randolph J ^a,b   Nowak, Elizabeth C ^a,b  

^a NORRIS COTTON CANCER CENTER   (United States)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; JANUS KINASE 1; JANUS KINASE 3; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN;

ALLERGY; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; MAST CELL; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKIN ALLOGRAFT; TH17 CELL; TH2 CELL; ANIMAL; IMMUNOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; HUMANS; INTERLEUKIN-9; KILLER CELLS, NATURAL; MAST CELLS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 77957228169     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2848     Document Type: Review

References (48)

1. Renauld, J. C. et al. Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc. Natl Acad. Sci. USA 89, 5690-5694 (1992).
2. Bauer, J. H., Liu, K. D., You, Y., Lai, S. Y. and Goldsmith, M. A. Heteromerization of the β chain with the interleukin-9 receptor α subunit leads to STAT activation and prevention of apoptosis. J. Biol. Chem. 273, 9255-9260 (1998). (Pubitemid 28176218)
3. Demoulin, J. B. et al. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol. Cell Biol. 16, 4710-4716 (1996).
4. Demoulin, J. B., Van Roost, E., Stevens, M., Groner, B. and Renauld, J. C. Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9. J. Biol. Chem. 274, 25855-25861 (1999). (Pubitemid 129530765)
5. Gessner, A., Blum, H. and Rollinghoff, M. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 189, 419-435 (1993). (Pubitemid 24008832)
6. Chang, H. C. et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nature Immunol. 11, 527-534 (2010).
7. Dardalhon, V. et al. IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3- effector T cells. Nature Immunol. 9, 1347-1355 (2008).
8. Veldhoen, M. et al. Transforming growth factor-? reprograms the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nature Immunol. 9, 1341-1346 (2008).
9. Staudt, V. et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 29 Jul 2010 (doi:10.1016/ j.immuni.2010.07.014).
10. Brustle, A. et al. The development of inflammatory TH-17 cells requires interferon-regulatory factor 4. Nature Immunol. 8, 958-966 (2007). (Pubitemid 47300010)
11. Lohoff, M. et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl Acad. Sci. USA 99, 11808-11812 (2002). (Pubitemid 34994480)
12. Rengarajan, J. et al. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195, 1003-1012 (2002). (Pubitemid 34412002)
13. Schmitt, E. et al. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-β and IL-4, and is inhibited by IFN-γ. J. Immunol. 153, 3989-3996 (1994). (Pubitemid 24322566)
14. Angkasekwinai, P., Chang, S. H., Thapa, M., Watarai, H. and Dong, C. Regulation of IL-9 expression by IL-25 signaling. Nature Immunol. 11, 250-256 (2010).
15. Wong, M. T. et al. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol. Cell Biol. 88, 624-631(2010).
16. Beriou, G. et al. TGF-β Induces IL-9 production from human Th17 cells. J. Immunol. 185, 46-54 (2010).
17. Putheti, P., Awasthi, A., Popoola, J., Gao, W. and Strom, T. B. Human CD4 memory T cells can become CD4+IL-9+ T cells. PLoS ONE 5, e8706 (2010).
18. Nowak, E. C. et al. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 206, 1653-1660 (2009).
19. Elyaman, W. et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl Acad. Sci. USA 106, 12885-12890 (2009).
20. Lu, L. F. et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442, 997-1002 (2006).
21. Liu, Y., Teige, I., Birnir, B. and Issazadeh-Navikas, S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nature Med. 12, 518-525 (2006).
22. Hill, J. A. et al. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi cells. Immunity 29, 758-770 (2008).
23. Stassen, M. et al. Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J. Immunol. 164, 5549-5555 (2000). (Pubitemid 30389793)
24. Wiener, Z., Falus, A. and Toth, S. IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice. Cytokine 26, 122-130 (2004). (Pubitemid 38596922)
25. Lauwerys, B. R., Garot, N., Renauld, J. C. and Houssiau, F. A. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J. Immunol. 165, 1847-1853 (2000). (Pubitemid 30643135)
26. Jones, T. G. et al. Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J. Immunol. 183, 5251-5260 (2009).
27. Nagato, T. et al. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients. Clin. Cancer Res. 11, 8250-8257 (2005). (Pubitemid 41746934)
28. Renauld, J. C., Goethals, A., Houssiau, F., Van Roost, E. and Van Snick, J. Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40. Cytokine 2, 9-12 (1990).
29. Townsend, J. M. et al. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13, 573-583 (2000).
30. Mesples, B., Fontaine, R. H., Lelievre, V., Launay, J. M. and Gressens, P. Neuronal TGF-?1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice. Neurobiol. Dis. 18, 193-205 (2005). (Pubitemid 40092909)
31. Miller, H. R., Wright, S. H., Knight, P. A. and Thornton, E. M. A novel function for transforming growth factor-β1: upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific β-chymase, mouse mast cell protease-1. Blood 93, 3473-3486 (1999).
32. Steenwinckel, V. et al. IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J. Immunol. 182, 4737-4743 (2009).
33. Steenwinckel, V. et al. IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J. Immunol. 178, 3244-3251 (2007). (Pubitemid 46333207)
34. Temann, U. A., Ray, P. and Flavell, R. A. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109, 29-39 (2002). (Pubitemid 34052539)
35. Whittaker, L. et al. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am. J. Respir. Cell. Mol. Biol. 27, 593-602 (2002). (Pubitemid 35301814)
36. Sitkauskiene, B. et al. Airway allergen exposure stimulates bone marrow eosinophilia partly via IL-9. Respir. Res. 6, 33 (2005). (Pubitemid 41358037)
37. Pilette, C. et al. IL-9 inhibits oxidative burst and TNF-β release in lipopolysaccharide-stimulated human monocytes through TGF-β. J. Immunol. 168, 4103-4111 (2002). (Pubitemid 34298418)
38. Pilette, C. et al. Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9. Eur. Respir. J. 20, 1198-1205 (2002). (Pubitemid 35331878)
39. Wu, B. et al. IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis. Clin. Immunol. 126, 202-210 (2008).
40. Cheng, G. et al. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am. J. Respir. Crit. Care Med. 166, 409-416 (2002). (Pubitemid 34864436)
41. Osterfeld, H. et al. Differential roles for the IL-9/IL-9 receptor β-chain pathway in systemic and oral antigen-induced anaphylaxis. J. Allergy Clin. Immunol. 125, 469-476, e462 (2010).
42. Li, H. et al. Neutralization of IL-9 amerliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J. Immunol. 30 Aug 2010 (doi:10.4049/jimmunol.1000986).
43. Jager, A., Dardalhon, V., Sobel, R. A., Bettelli, E. and Kuchroo, V. K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169-7177 (2009).
44. Peron, J. P. et al. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice. J. Neuroimmunol. 25 Jun 2010 (doi:10.1016/j.neuroim.2010.06.002).
45. Khan, W. I. et al. Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections. Infect. Immun. 71, 2430-2438 (2003).
46. Forbes, E. E. et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J. Exp. Med. 205, 897-913 (2008).
47. Richard, M., Grencis, R. K., Humphreys, N. E., Renauld, J. C. and Van Snick, J. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc. Natl Acad. Sci. USA 97, 767-772 (2000). (Pubitemid 30070384)
48. de Vries, V. C. et al. Mast cell degranulation breaks peripheral tolerance. Am. J. Transplant 9, 2270-2280 (2009).